These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4764220)

  • 1. [Interaction of streptomycin, Tubazid and PAS according to myorelaxant and lethal effects].
    Soloviev NV; Berezhinskaia VV
    Antibiotiki; 1973 Mar; 18(3):249-52. PubMed ID: 4764220
    [No Abstract]   [Full Text] [Related]  

  • 2. [The clinical significance of the critical drug resistance concentration of SM,INH and PAS].
    Baba H; Azuma Y
    Kekkaku; 1972 Oct; 47(10):353-60. PubMed ID: 4658707
    [No Abstract]   [Full Text] [Related]  

  • 3. [[Comparative studies on therapeutic effects of SM.INH.PAS, SM.INH.PAS.EB twice weekly, and SM.INH.PAS.EB daily in original treatment cases of pulmonary tuberculosis].
    Kekkaku; 1971 Aug; 46(8):325-33. PubMed ID: 4998863
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanism of action and effectiveness of intravenous administration of tubazid, streptomycin and PAS in the therapy of pulmonary tuberculosis].
    Pilipchuk NS; Ivaniuota OM; Kovalenko NN
    Probl Tuberk; 1970; 48(1):26-30. PubMed ID: 5425441
    [No Abstract]   [Full Text] [Related]  

  • 5. [The function of the cardiovascular system in patients with pulmonary tuberculosis treated by intravenous administration of streptomycin, tubazid and PAS].
    Golanov VS
    Vrach Delo; 1969 Jun; 6():62-6. PubMed ID: 5821665
    [No Abstract]   [Full Text] [Related]  

  • 6. [The hemogram and ESR in pulmonary tuberculosis during intravenous administration of the primary antitubercular drugs].
    Koviazina AI; Utkin VV
    Probl Tuberk; 1971; 49(2):48-51. PubMed ID: 5561919
    [No Abstract]   [Full Text] [Related]  

  • 7. [Disorders of carbohydrate metabolism after administration of isoniazid, streptomycin and PAS and their correction with thiamine and nicotinic acid].
    Chirkin AA; Romanovskiĭ RV; Solov'ev IuA
    Probl Tuberk; 1986; (5):61-4. PubMed ID: 3737600
    [No Abstract]   [Full Text] [Related]  

  • 8. [Morphological changes in the liver of healthy guinea pigs following long term administration of streptomycin, phthivazid and PAS].
    Pudaĭtene AP
    Probl Tuberk; 1969; 47(4):72-5. PubMed ID: 5392351
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ethambutol combined with streptomycin and isoniazid for the original treatment cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hayashi N; Hibino S
    Kekkaku; 1970 Feb; 45(2):55-60. PubMed ID: 5439133
    [No Abstract]   [Full Text] [Related]  

  • 10. Sensitivity to streptomycin, isoniazid and para-aminosalicylic acid of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):69-74. PubMed ID: 6819092
    [No Abstract]   [Full Text] [Related]  

  • 11. [Our region's possibilities in the ambulatory treatment of pulmonary tuberculosis with the biweekly administration of a perfused triple combination of isoniazid, streptomycin and PAS].
    Burghard G; Petitjean R; Scherrer B; Schranz J
    Rev Tuberc Pneumol (Paris); 1970; 34(5):662-3. PubMed ID: 5496786
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of antituberculosis chemotherapy in vitro under various conditions inadequate for the growth of tubercle bacilli. II. Antituberculosis activity of INH and SM in vitro after exposure to PAS.
    Maekawa N; Nakanishi ; Kawai M; Ikeda N; Nakai H
    Kekkaku; 1971 Aug; 46(8):293-4. PubMed ID: 4998861
    [No Abstract]   [Full Text] [Related]  

  • 13. [Severe hypersensitivity to SM, INH and PAS in a child with post-primary tuberculosis].
    Rykowska Z
    Gruzlica; 1969 Aug; 37(8):777-81. PubMed ID: 4242816
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of initial combined chemotherapy with SM, INH and EB for pulmonary tuberculosis. 2. Comparison of SM, EB and INH regimen with that of SM, PAS and INH for experimental tuberculosis of mice].
    Makiyama H
    Kekkaku; 1971 Aug; 46(8):303-8. PubMed ID: 5570128
    [No Abstract]   [Full Text] [Related]  

  • 15. Course of cases of pulmonary tubercurosis with bacilli resistant to streptmycin, para-aminosalicylic acid and isoniazid and with multiple drug-resistance.
    Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1969 Dec; 16(3):106-9. PubMed ID: 4988512
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study (tolerance and effectiveness) of classic antituberculous therapy (P.A.S.-streptomycin-isoniazid) and a new combination (prothionamide-streptomycin-isoniazid)].
    Charpin J; Taranger J; Boutin C; Girbal JP
    Mars Med; 1969; 106(11):895-7. PubMed ID: 5407168
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative study of biweekly streptomycin and isoniazid with daily P.A.S. and isoniazid regimens in the treatment of pulmonary tuberculosis.
    Mathur JB; Bahadur P; Agnihotri CB
    J Indian Med Assoc; 1967 Aug; 49(4):162-5. PubMed ID: 5594009
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of 1st line antitubercular preparations on the fibrinolytic system].
    Khudzik LD; Gladilin GP; Blagova LM
    Farmakol Toksikol; 1973; 36(1):82-4. PubMed ID: 4685160
    [No Abstract]   [Full Text] [Related]  

  • 19. Twice-weekly streptomycin plus isoniazid for tuberculosis.
    Stradling P; Poole GW
    Tubercle; 1970 Mar; 51(1):44-7. PubMed ID: 5495335
    [No Abstract]   [Full Text] [Related]  

  • 20. [Resensitization of resistant mycobacterial strains to antitubercular drugs].
    Vercellino E
    G Mal Infett Parassit; 1968 Feb; 20(2):191-3. PubMed ID: 4984621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.